Exploring the Potential Medicinal Benefits of Ganoderma lucidum: From Metabolic Disorders to Coronavirus Infections
Author | Ekiz, Elif |
Author | Oz, Emel |
Author | Abd El-Aty, A. M. |
Author | Proestos, Charalampos |
Author | Brennan, Charles |
Author | Zeng, Maomao |
Author | Tomasevic, Igor |
Author | Elobeid, Tahra |
Author | Çadırcı, Kenan |
Author | Bayrak, Muharrem |
Author | Oz, Fatih |
Available date | 2023-05-14T11:20:33Z |
Publication Date | 2023-04-01 |
Publication Name | Foods |
Identifier | http://dx.doi.org/10.3390/foods12071512 |
Citation | Ekiz, E., Oz, E., Abd El-Aty, A. M., Proestos, C., Brennan, C., Zeng, M., ... & Oz, F. (2023). Exploring the Potential Medicinal Benefits of Ganoderma lucidum: From Metabolic Disorders to Coronavirus Infections. Foods, 12(7), 1512. |
Abstract | Ganoderma lucidum is a medicinal mushroom that has been traditionally used in Chinese medicine for centuries. It has been found to have a wide range of medicinal properties, including antioxidant, anti-inflammatory, and immune-boosting effects. Recent research has focused on the potential benefits of G. lucidum in treating metabolic disorders such as diabetes and obesity, as well as its possible role in preventing and treating infections caused by the coronavirus. Triterpenoids are a major group of bioactive compounds found in G. lucidum, and they have a range of biological activities, including anti-inflammatory and antioxidant properties. These compounds have been found to improve insulin sensitivity and lower blood sugar levels in animal models of diabetes. Additionally, G. lucidum polysaccharides have been found to reduce bodyweight and improve glucose metabolism in animal models of obesity. These polysaccharides can also help to increase the activity of certain white blood cells, which play a critical role in the body’s immune response. For coronavirus, some in vitro studies have shown that G. lucidum polysaccharides and triterpenoids have the potential to inhibit coronavirus infection; however, these results have not been validated through clinical trials. Therefore, it would be premature to draw any definitive conclusions about the effectiveness of G. lucidum in preventing or treating coronavirus infections in humans. |
Language | en |
Publisher | MDPI |
Subject | anticancer antidiabetic antioxidant bioactive compounds cardiovascular diseases COVID-19 Ganoderma lucidum |
Type | Article |
Issue Number | 7 |
Volume Number | 12 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
COVID-19 Research [811 items ]
-
Human Nutrition [373 items ]